Cox Carrie Smith

SEC CIK: 0001110753

SEC filings (opens in a new tab)

In the past year, 1 open-market purchase filing worth $501.6K and 1 sale filing worth $2.71M.

Current role at each company

SOLV Solventum CorpDirectoras of May 18, 2026
TXN Texas Instruments IncDirectoras of May 14, 2026
OGN Organon & Co.Executive Chairas of Nov 13, 2025
RNAC Cartesian Therapeutics, Inc.Directoras of Jan 6, 2025
CAH Cardinal Health IncDirectoras of Nov 10, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: $501.6K; 1 filing
Sold: $2.71M; 1 filing
Net: −$2.21M; Bought minus sold
Companies: 2; With open-market trades

Trades

Every Form 4 that lists Cox Carrie Smith as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

TXN Texas Instruments Inc

Director2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
May 14, 2026 (view filing)	May 13	1 day	Cox Carrie SmithDirector	SSale	−8.84K	$306.40	−$2.71M	−19.0%37.6K after	2 lots
Aug 3, 2023 (view filing)	Jul 31	3 daysLate	Cox Carrie SmithDirector	SSale	−16.1K	$180.04	−$2.89M	−31.0%35.8K after

OGN Organon & Co.

Executive Chair2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 13, 2025 (view filing)	Nov 12	1 day	Cox Carrie SmithExecutive Chair	PPurchase	+65.4K	$7.67	+$501.6K	+524.5%77.9K after
May 15, 2025 (view filing)	May 14	1 day	Cox Carrie SmithDirector	PPurchase	+12.5K	$8.07	+$100.6K	New position12.5K after

RNAC Cartesian Therapeutics, Inc.